Updated May 24, 2019

Eliminate the cold chain with low-cost liquid viral vaccines

http://gcgh.grandchallenges.org/grant/eliminate-cold-chain-low-cost-liquid-viral-vaccines

The innovation has no owner

Claim it

Tarit Mukhopadhyay of University College London in the United Kingdom and Stephen Ward of Stabilitech are working to apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.
Tarit Mukhopadhyay of University College London in the United Kingdom and Stephen Ward of Stabilitech are working to apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.
SEE LESS
Transport
  

Stage 2: Research & Development

Tarit Mukhopadhyay of University College London in the United Kingdom and Stephen Ward of Stabilitech are working to apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.
Registered in United Kingdomin United Kingdom

Focus Areas:

Health, Infectious & Vector Diseases and Prevention & Vaccination

Health, Infectious & Vector Diseases and Prevention & VaccinationSEE LESS

Implemented In:

Ireland and United Kingdom

Ireland and United KingdomSEE LESS

2
Countries Implemented In

Milestone

Date Unknown
Created
Date Unknown
New Country Implemented In
United Kingdom
Date Unknown
New Country Implemented In
Ireland